A 52-year-old man with a history of tuberculosis (treated 2 years ago) presents with a 2-month history of progressive weakness, bleeding gums, and recurrent infections. Physical examination reveals splenomegaly and generalized lymphadenopathy. Complete blood count shows: Hemoglobin 8.5 g/dL, WBC 1800/μL, platelets 60,000/μL. Peripheral blood smear reveals hypersegmented neutrophils and macro-ovalocytes. Serum B12 is 180 pg/mL (normal >200). Bone marrow biopsy shows megaloblastic erythropoiesis with normal cellularity. What is the most appropriate next investigation to confirm the diagnosis?

Explanation

## Diagnostic Approach to Megaloblastic Anemia with Low B12 ### Clinical Presentation Summary **Key Point:** This patient has pancytopenia with megaloblastic bone marrow changes and low B12 (180 pg/mL). The next step is to differentiate B12 deficiency from folate deficiency, as both can present identically. ### Why Serum Folate and Methylmalonic Acid? | Investigation | Interpretation in B12 Deficiency | Interpretation in Folate Deficiency | |---|---|---| | **Serum B12** | Low | Normal | | **Serum Folate** | Normal or low (depleted by B12 deficiency) | Low | | **Methylmalonic acid (MMA)** | **Elevated** ✓ | Normal | | **Homocysteine** | Elevated | Elevated | **High-Yield:** Methylmalonic acid is the most specific marker for B12 deficiency. It is elevated ONLY in B12 deficiency (not folate deficiency), making it the gold-standard confirmatory test. ### Pathophysiology: Why MMA Distinguishes B12 from Folate Deficiency ```mermaid flowchart TD A[Low B12]:::outcome --> B[Impaired methylmalonyl-CoA mutase]:::action B --> C[Methylmalonic acid accumulates]:::outcome D[Low Folate]:::outcome --> E[Impaired thymidylate synthase]:::action E --> F[Megaloblastosis only]:::outcome C --> G[MMA elevated]:::urgent F --> H[MMA normal]:::action ``` ### Clinical Pearl **Clinical Pearl:** In this case, the patient has a history of TB (treated 2 years ago). TB treatment with rifampicin and isoniazid can cause B12 deficiency through malabsorption and reduced intrinsic factor production. The splenomegaly and lymphadenopathy suggest possible TB relapse or sequelae, which may have contributed to B12 malabsorption. ### Diagnostic Algorithm for Megaloblastic Anemia 1. **Step 1:** Confirm megaloblastosis on bone marrow (✓ done) 2. **Step 2:** Check B12 and folate levels (✓ B12 low at 180 pg/mL) 3. **Step 3:** Measure methylmalonic acid and homocysteine - If MMA elevated → **B12 deficiency confirmed** - If MMA normal, homocysteine elevated → **Folate deficiency** 4. **Step 4:** Determine cause of B12 deficiency (pernicious anemia vs. malabsorption vs. dietary) ### Why NOT the Other Options? **Intrinsic factor and parietal cell antibodies** (Option B) are used to diagnose pernicious anemia (autoimmune cause of B12 deficiency), but they come AFTER confirming B12 deficiency with MMA. **Schilling test** (Option C) is rarely used now; it was historically used to differentiate intrinsic factor deficiency from malabsorption. Serum MMA is more practical and available. **Reticulocyte count and LDH** (Option D) assess hemolysis, not B12 status. These are non-specific in megaloblastic anemia. **Mnemonic for B12 deficiency causes — ABCDEFG:** - **A**lcoholism (poor diet) - **B**ariatric surgery - **C**rohn's disease (terminal ileum) - **D**ietary (vegans) - **E**xtrinsic factor antibodies (pernicious anemia) - **F**ish tapeworm (Diphyllobothrium) - **G**astric surgery (gastrectomy) [cite:Harrison 21e Ch 110]